Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02262377 · ClinicalTrials.gov registry record · NA

Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression

A NA study of Depression and Chronic Pain, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
159
Enrollment target
1
Study location

NCT02262377 is a NA study of Depression and Chronic Pain that has completed, run by Boston Medical Center. The registered enrollment target is 159 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02262377, a NA study of Depression and Chronic Pain, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
159 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether Integrative Medicine Group Visits (IMGV) are effective for treating patients with chronic pain and depression.

Conditions Studied

Interventions

  • BEHAVIORAL Integrative Medicine Group Visits

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 159 participants
Start Date 2015-04
Est. Completion 2016-11
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT02262377

The ClinicalTrials.gov registry entry for NCT02262377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Integrative Medicine Group Visits is the first listed.

NCT02262377 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02262377 about?

NCT02262377 is a clinical study titled "Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression". The purpose of this study is to determine whether Integrative Medicine Group Visits (IMGV) are effective for treating patients with chronic pain and depression.

What is the current status of trial NCT02262377?

This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2015-04. Estimated completion is 2016-11.

What conditions does trial NCT02262377 study?

This clinical trial studies the following conditions: Depression, Chronic Pain.

What interventions are being tested in trial NCT02262377?

The interventions under investigation include: Integrative Medicine Group Visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT02262377?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02262377 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.